Jamieson is delighted to announce it has advised the management team of Cosette Pharmaceuticals (“Cosette”) on the terms of the management incentive plan in connection with the significant equity investment by Hamilton Lane.
Cosette is a US-based specialty pharmaceutical company with a proven topicals and dermatology portfolio and a growing branded pharmaceuticals business. Cosette has a deep focus on internal R&D, high quality manufacturing standards and commercial sales excellence. The transaction enhances Cosette’s balance sheet to continue to drive growth through investments in R&D and strategic acquisitions.
Michael Sirkin, John Greenland, and Evan Alper advised the management team on the transaction.
